HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuroprotection and intracellular Ca2+ modulation with fructose-1,6-bisphosphate during in vitro hypoxia-ischemia involves phospholipase C-dependent signaling.

Abstract
The neuroprotectant fructose-1,6-bisphosphate (FBP) preserves cellular [ATP] and prevents catastrophic increases in [Ca2+]i during hypoxia. Because FBP does not enter neurons or glia, the mechanism of protection is not clear. In this study, we show that FBP's capacity to protect neurons and stabilize [Ca2+]i during hypoxia derives from signaling by a phospholipase-C-intracellular Ca2+-protein kinases pathway, rather than Ca2+ chelation or glutamate receptor inhibition. FBP reduced [Ca2+]i changes in hypoxic hippocampal neurons, regardless of [Ca2+]e, and preserved cellular integrity as measured by trypan blue or propidium iodide exclusion and [ATP]. FBP also prevented hypoxia-induced increases in [Ca2+]i when glucose was absent and when [Ca2+]e was increased to negate Ca2+ chelation by FBP. These protective effects were observed equally in postnatal day 2 (P2) and P16 neurons. Inhibiting glycolysis with iodoacetate eliminated the protective effects of FBP in P16 neurons. FBP did not alter Ca2+ influx stimulated by brief applications of NMDA or glutamate during normoxia or hypoxia, but did reduce the increase in [Ca2+]i produced by 10 min of glutamate exposure during hypoxia. Because FBP increases basal [Ca2+]i and stimulates membrane lipid hydrolysis, we tested whether FBP's protective action was dependent on phospholipase C signaling. The phospholipase C inhibitor U73122 prevented FBP-induced increases in [Ca2+]i and eliminated FBP's ability to stabilize [Ca2+]i and increase survival during anoxia. Similarly, FBP's protection was eliminated in the presence of the mitogen/extracellular signal protein kinase (MEK) inhibitor U0126. We conclude that FBP may produce neuroprotection via activation of neuroprotective signaling pathways that modulate Ca2+ homeostasis.
AuthorsP H Donohoe, C S Fahlman, P E Bickler, Z S Vexler, G A Gregory
JournalBrain research (Brain Res) Vol. 917 Issue 2 Pg. 158-66 (Nov 02 2001) ISSN: 0006-8993 [Print] Netherlands
PMID11640901 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Fructosediphosphates
  • Neuroprotective Agents
  • Receptors, Glutamate
  • Adenosine Triphosphate
  • Type C Phospholipases
  • fructose-1,6-diphosphate
  • Calcium
Topics
  • Adenosine Triphosphate (metabolism)
  • Animals
  • Brain Ischemia (metabolism)
  • Calcium (metabolism)
  • Cell Survival (drug effects)
  • Fructosediphosphates (pharmacology)
  • Hypoxia (metabolism)
  • In Vitro Techniques
  • Intracellular Membranes (metabolism)
  • Mice
  • Neuroprotective Agents (pharmacology)
  • Osmolar Concentration
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Glutamate (physiology)
  • Signal Transduction (physiology)
  • Type C Phospholipases (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: